Loser V, Vicino A, Theaudin M
Front Neurol. 2024; 15:1495205.
PMID: 39555481
PMC: 11565704.
DOI: 10.3389/fneur.2024.1495205.
Quinot V, Rostasy K, Hoftberger R
J Clin Med. 2024; 13(19).
PMID: 39407781
PMC: 11477122.
DOI: 10.3390/jcm13195721.
Funakoshi K, Kokubun N, Suzuki K, Yuki N
Eur J Neurol. 2024; 31(10):e16406.
PMID: 38980226
PMC: 11414813.
DOI: 10.1111/ene.16406.
Chen J, Liu L, Zhu H, Han J, Li R, Gong X
Front Immunol. 2024; 15:1308068.
PMID: 38524138
PMC: 10957541.
DOI: 10.3389/fimmu.2024.1308068.
Shida R, Iwakura T, Ohashi N, Ema C, Aoki T, Tashiro T
Intern Med. 2024; 63(5):699-705.
PMID: 38432895
PMC: 10982023.
DOI: 10.2169/internalmedicine.2126-23.
CIDP/autoimmune nodopathies with nephropathy: a case series study.
Tang Y, Liu J, Gao F, Hao H, Jia Z, Zhang W
Ann Clin Transl Neurol. 2023; 10(5):706-718.
PMID: 36932648
PMC: 10187714.
DOI: 10.1002/acn3.51754.
Nodo-paranodopathies: Concepts, Clinical Implications, and Management.
Khadilkar S, Kamat S, Patel R
Ann Indian Acad Neurol. 2023; 25(6):1001-1008.
PMID: 36911467
PMC: 9996523.
DOI: 10.4103/aian.aian_382_22.
Contactin-1 links autoimmune neuropathy and membranous glomerulonephritis.
Fehmi J, Davies A, Antonelou M, Keddie S, Pikkupeura S, Querol L
PLoS One. 2023; 18(3):e0281156.
PMID: 36893151
PMC: 9997925.
DOI: 10.1371/journal.pone.0281156.
Value of Antibody Determinations in Chronic Dysimmune Neuropathies.
Tozza S, Spina E, Iovino A, Iodice R, Dubbioso R, Ruggiero L
Brain Sci. 2023; 13(1).
PMID: 36672019
PMC: 9856104.
DOI: 10.3390/brainsci13010037.
Effect of low-dose rituximab treatment on autoimmune nodopathy with anti-contactin 1 antibody.
Hou Y, Zhang C, Yu X, Wang W, Zhang D, Bai Y
Front Immunol. 2022; 13:939062.
PMID: 35958552
PMC: 9362773.
DOI: 10.3389/fimmu.2022.939062.
Characteristics of Anti-Contactin1 Antibody-Associated Autoimmune Nodopathies With Concomitant Membranous Nephropathy.
Xu Q, Liu S, Zhang P, Wang Z, Chang X, Liu Y
Front Immunol. 2021; 12:759187.
PMID: 34675937
PMC: 8523937.
DOI: 10.3389/fimmu.2021.759187.
Evolving Immunologic Perspectives in Chronic Inflammatory Demyelinating Polyneuropathy.
Rajabally Y, Attarian S, Delmont E
J Inflamm Res. 2020; 13:543-549.
PMID: 32982369
PMC: 7502403.
DOI: 10.2147/JIR.S224781.
Distinguish CIDP with autoantibody from that without autoantibody: pathogenesis, histopathology, and clinical features.
Tang L, Huang Q, Qin Z, Tang X
J Neurol. 2020; 268(8):2757-2768.
PMID: 32266541
DOI: 10.1007/s00415-020-09823-2.
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype.
Cortese A, Lombardi R, Briani C, Callegari I, Benedetti L, Manganelli F
Neurol Neuroimmunol Neuroinflamm. 2019; 7(1).
PMID: 31753915
PMC: 6935837.
DOI: 10.1212/NXI.0000000000000639.
